Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trial
Conclusion:
Our current study will provide important imaging-derived data that may add relevance to the clinically derived outcomes from liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results and semaglutide and cardiovascular outcomes in patients with type 2 diabetic mellitus 6 trials.
Source: Coronary Artery Disease - Category: Cardiology Tags: Clinical Trial Design Source Type: research
More News: Angiography | Calcium | Cardiology | Cardiovascular | Clinical Trials | CT Scan | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Study | Victoza